Nevertheless, this study provides evidence that PALLD is a pancreatic cancer susceptibility gene, likely through the presence of an abnormal palladin gene in stromal CAFs, therefore defining a carcinogenic tumor microenvironment that favors distinct mutagenic alteration in pancreatic ductal cells. The gene discussed is PALLD; the disease is familial pancreatic carcinoma.